India Diagnostics Market: By Type (Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics and Others), By Product Type (Instruments/Analysers and Reagents & Kits), By Application (Infectious Disease, Oncology, Hormone, Diabetes, Cardiac and Others), By End User (Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories and Others) and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

India Diagnostics Market size is anticipated to be valued at USD 2,013.5 million in 2021, and it is expanded to grow at a significant CAGR of 16.3% over 2022-2028. Increasing demand for novel healthcare facilities, rise in awareness of various diseases, health consciousness among people, growing per capita income, and high need for regular health check-ups in recent periods in India will be expected to drive the India diagnostics market over the forecast period. Rising awareness of communicable and non-communicable diseases among the population and subsequent preventive/treatment measures by regular monitoring of health with frequent check-ups under physician guidance is also a significant factor to drive the diagnostics market over the forecast period. The Indian diagnostics market players are majorly focusing on the majority of the in-vitro diagnostic products. However, while entering into new domains or developing a new product that has a more lucrative opportunity in the Indian IVD market, these companies follow a few strategic procedures. For instance, The Agappe company has focused on the hematology domain and started developing hematology analyzers. The company hired a clinical guide and a technical expert who has worked in several multinational corporations' research and development departments to develop this product. Finally, the company developed and launched India's first indigenous three-part diff hematology system. In 2021, the clinical chemistry segment accounted for a larger revenue share and projected to grow with a CAGR of 15.4% from 2020-2026, owing to the launch of newer diagnostics products.

Recent Market Developments:

In March 2022, Trivitron Healthcare acquires US-based medical devices firm Kennedy Company. The acquisition will allow the Chennai-based Trivitron to get a 7 acres’ campus with 25,000 square feet of production space in Scottsboro, Alabama. In Dec. 8, 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.

India Diagnostics Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

India Diagnostics Market

Government initiatives toward public health awareness programs, frequent rural camps for healthcare services, and free medical support for people who don’t have access to medical check-ups are also considerable factors driving the overall healthcare industry in India. Investments from private companies in healthcare industries and public and private companies’ projects to raise awareness of public health and wellness programs in recent periods in India are also a few significant factors expected to drive the India diagnostics market over the forecast period. Imports from other countries act as a growth restraint in the worldwide India diagnostics market. India diagnostics market is highly fragmented and unorganized due to the lack of regulations.

Key Features of the Reports

  • The India diagnostics market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

India Diagnostics Market Segmentation

By Type
  • Immunodiagnostics
  • Clinical Chemistry
  • Tissue Diagnostics
  • Haematology
  • Point of Care Tests
  • Molecular Diagnostics
  • Others
By Product Type
  • Instruments/Analysers
  • Reagents and Kits
By Application
  • Infectious Disease
  • Oncology
  • Hormone
  • Diabetes
  • Cardiac
  • Others
By End User
  • Diagnostic Chains
  • Individual Diagnostic Laboratories
  • Hospital Laboratories
  • Others

Frequently Asked Questions

The India Diagnostics Market is projected to expand at a CAGR of 16.3% during the forecast period.

Trivitron healthcare., Accurex diagnostics, Sysmex Corporation, ThermoFisher scientific, Ortho clinical diagnostics

[urltag url='request-table-of-content']

Competition Assessment

Key player’s profiles in the India diagnostics market include:

  • Roche Diagnostics India Private Limited
  • Siemens Ltd. (Siemens Healthineers India)
  • Becton Dickinson India Pvt Ltd
  • Beckman Coulter India Private Limited
  • Abbott India
  • Transasia Bio-Medicals Limited
  • Tulip Diagnostics Pvt Ltd
  • Trivitron Healthcare Pvt Ltd
  • Agappe Diagnostics Limited
  • Accurex Biomedical Pvt Ltd